United Kingdom · Question · Written question
UIN 200050
Diabetes: Tirzepatide
Original
Introduced
18 September 2023
Last action
16 October 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
16 October 2023
Summary
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of the NHS using Tirzepatide to treat patients with diabetes when Ozempic is not available.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
18 September 2023
Written question
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of the NHS using Tirzepatide to treat patients with diabetes when Ozempic is not available.
Source: Commons
16 October 2023
Answer
The relative merits of Tirzepatide compared to other treatments in any indication is subject to appraisal by the National Institute for Health and Care Excellence (NICE), which provides recommendations to the National Health Service on a drug’s clinical a...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-09-18/200050
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1661333
- uk · wq-1661333 · source updated 16 October 2023